Updated Jul 16, 2026
Rothenberg Mace has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $74K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | TNGX | Tango Therapeutics, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2024-11-18 | TNGX | Tango Therapeutics, Inc. | P — Open-market purchase | 10.0K | $3.78 | $38K |
| 2024-11-18 | TNGX | Tango Therapeutics, Inc. | P — Open-market purchase | 10.0K | $3.62 | $36K |
Rothenberg Mace is a corporate insider — currently tracked as Insider of Tango Therapeutics, Inc. (TNGX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($74K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Rothenberg Mace profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.